Side-by-Side Comparison
| Generic Truvada (TDF/FTC) | Descovy (TAF/FTC) | |
|---|---|---|
| Active ingredients | Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg | Emtricitabine 200mg + Tenofovir Alafenamide 25mg |
| Manufacturer | Multiple generic manufacturers | Gilead Sciences (brand only) |
| FDA approved for PrEP | 2012 | 2019 |
| How you take it | One pill daily | One pill daily |
| Effectiveness | Up to 99% (when taken as prescribed) | Up to 99% (when taken as prescribed) |
| Approved populations | All populations at risk (MSM, women, PWID) | NOT approved for receptive vaginal sex risk |
| On-demand (2-1-1) dosing | Yes (MSM only) | No |
| Kidney safety | Slight, generally reversible decline in kidney function in some users | Better kidney safety profile |
| Bone safety | Slight decrease in bone mineral density | Better bone safety profile |
| Weight effects | Less weight gain observed | Slightly more weight gain observed |
| List price (no insurance) | $27–$60/mo with coupon | $2,200–$2,944/mo |
| With insurance (ACA) | $0 | $0 |
| Manufacturer PAP | No (Gilead discontinued free Truvada Jan 2025) | Free via Gilead Advancing Access (≤500% FPL) |
| Generic available? | Yes — 8+ manufacturers | No (brand only through at least 2026) |
Effectiveness: A Tie
Both Descovy and generic Truvada are up to 99% effective at preventing HIV when taken daily as prescribed. The DISCOVER trial — the head-to-head study that led to Descovy's approval — found no statistically significant difference in HIV prevention between the two drugs. Both work by blocking HIV's reverse transcriptase enzyme, preventing the virus from establishing infection.
The real-world effectiveness of any PrEP medication depends primarily on adherence — taking the pill consistently. Studies show that PrEP effectiveness drops significantly with inconsistent use. The best PrEP is the one you'll actually take every day.
Side Effects: Descovy Has a Slight Edge
Both medications share common startup side effects like headache, nausea, and stomach discomfort — these typically resolve within the first few weeks. The meaningful differences are in long-term organ impacts.
Kidney function
Truvada (TDF) can cause a small, generally reversible decline in kidney function in some users. Descovy (TAF) delivers tenofovir more efficiently, resulting in lower systemic exposure and fewer kidney effects. If you have existing kidney concerns or are taking other kidney-affecting medications, Descovy is the safer choice. Your provider will monitor kidney function with regular lab work regardless of which medication you take.
Bone mineral density
Truvada can cause a slight decrease in bone mineral density. Descovy shows better bone safety. However, clinical trials have not shown an increase in fracture rates with Truvada use for PrEP — the bone density changes are measurable but not clinically significant for most healthy adults. This may matter more for older adults or people with existing osteoporosis risk.
Weight and metabolic effects
Descovy is associated with slightly more weight gain and lipid changes than Truvada. This is a trade-off — better kidney/bone safety, but more metabolic effects. Neither drug causes dramatic weight changes for most people, but it's worth discussing with your provider if you have metabolic concerns.
Cost: Generic Truvada Wins by a Mile
This is the biggest practical difference between the two medications — and it only matters if you're paying out of pocket.
With insurance: both cost $0
Under the ACA, private insurance must cover all FDA-approved PrEP medications at zero cost-sharing. This was confirmed by the Supreme Court in Kennedy v. Braidwood Management (June 2025). Medicaid covers both at $0 in all states. If you have insurance, the cost difference between Descovy and generic Truvada is irrelevant — both are free.
Without insurance: Generic Truvada costs as little as $27–$60/month with a GoodRx or SingleCare coupon. Descovy costs $2,200–$2,944/month at retail and has no generic version in the U.S.
Here's the paradox: if you're uninsured, you can get brand-name Descovy for free through Gilead Advancing Access (for patients under 500% FPL), but generic Truvada has no manufacturer assistance program — Gilead discontinued free Truvada through Advancing Access on January 31, 2025. So an uninsured person who qualifies for Gilead's program can actually get the more expensive drug for free while the cheaper drug costs $27–$60/month. For a full breakdown of every cost pathway, see our PrEP Cost Guide.
Which One Should You Choose?
Choose Generic Truvada if...
You're paying out of pocket and want the cheapest option
You're a cisgender woman (Descovy isn't approved for vaginal sex exposure)
You want the option of on-demand (2-1-1) dosing instead of daily pills
You inject drugs (Descovy isn't studied for this route)
You don't have kidney or bone concerns
Best for: most people, especially without insurance
Choose Descovy if...
You have kidney function concerns or take kidney-affecting medications
You have osteoporosis risk or bone density concerns
You have insurance (it's free anyway — might as well get the newer formulation)
You're uninsured but qualify for Gilead Advancing Access (free Descovy)
Your provider recommends it based on your health profile
Best for: people with kidney/bone concerns, or anyone with insurance
Critical for cisgender women
Descovy was not studied in cisgender women for PrEP and is not FDA-approved for people whose primary risk is receptive vaginal sex. If you're a cisgender woman, your oral PrEP options are generic Truvada (TDF/FTC) or the injectable options Apretude and Yeztugo. Yeztugo showed 100% efficacy in cisgender women in the PURPOSE 1 trial.
Beyond Pills: Injectable PrEP
If you're deciding between Descovy and Truvada, it's worth knowing that daily pills aren't your only option anymore. Two injectable PrEP medications are now FDA-approved: Apretude (every 2 months) and Yeztugo (every 6 months). Both are covered at $0 with insurance and have free patient assistance programs for the uninsured. If adherence to a daily pill is a concern, injectable PrEP may be a better fit. See our injectable PrEP guide for details.
Get PrEP delivered free — Truvada or Descovy
MISTR prescribes both generic Truvada and Descovy, with free labs, consultations, and monthly delivery in all 50 states. Your physician will recommend the best option for you.
Start Free PrEP with MISTR →
Use code ANDR735 at signup. Using this code helps keep FreePrEP.org running and supports free PrEP access for everyone.
Frequently Asked Questions
They're equally effective at preventing HIV. Descovy has slightly better kidney and bone safety. Generic Truvada is dramatically cheaper without insurance, is approved for all populations (including women), and supports on-demand dosing. "Better" depends on your specific health profile and insurance status.
No. As of 2026, Descovy has no generic available in the United States. A generic has been approved in Europe but is not yet commercially available here. Generic Truvada (TDF/FTC) is widely available from 8+ manufacturers.
Descovy is not FDA-approved for individuals whose primary HIV risk is receptive vaginal sex — this population wasn't included in the DISCOVER trial. Cisgender women should use generic Truvada (TDF/FTC), Apretude, or Yeztugo for PrEP.
Nothing clinically meaningful. Generic Truvada contains the same active ingredients (emtricitabine + tenofovir disoproxil fumarate) at the same doses. Generics are FDA-tested for bioequivalence. The difference is price: brand Truvada costs ~$1,682/month, generics start at $27/month with a coupon.
Yes. You can switch between Descovy and generic Truvada with your provider's guidance. There's no required washout period. Some insurers may require a step therapy attempt with generic Truvada before covering Descovy.
Related guides
PrEP Cost Guide — Full pricing for all 4 PrEP medications
Apretude Cost Guide — Injectable PrEP pricing
Injectable PrEP Guide — Apretude and Yeztugo explained
MISTR Review — How to get free PrEP online